Clinical and experimental immunosuppression
Castillo Lugo, J.A.
Boletin de la Asociacion Medica de Puerto Rico 87(5-6): 106-108
1995
ISSN/ISBN: 0004-4849 PMID: 8573248 Document Number: 453666
Document emailed within 1 workday
Related Documents
Hatala, M.; Liska, M.; Spousta, J.; Málek, P. 1971: Therapy of experimental infection using gentamycin and carbenicillin during immunosuppression Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 50(4): 206-211Guimarães, A.C.; Kawarabayashi, M.; Nunes, E.V.; Ferraz, S.N.; Chiosini, C.B.; Tolezano, J.E.; Gama-Rodrigues, J.J.; Okumura, M. 1997: Experimental toxoplasmosis, and immunosuppression (parasite evaluation and histological alterations) Revista do Hospital das Clinicas 52(6): 316-320
Gogi, R.; Hajela, R.; Nath, K. 1983: Morphology of fungal corneal ulcers--influence of immunosuppression (an experimental study) Indian Journal of Ophthalmology 31(4): 405-407
Marshall, J.C.; Christou, N.V.; Meakins, J.L. 1988: Small-bowel bacterial overgrowth and systemic immunosuppression in experimental peritonitis Surgery 104(2): 404-411
Górski, A.; Grieb, P. 1994: Cladribine (2-chloro-2'-deoxyadenosine): new perspectives in clinical immunosuppression Archivum Immunologiae et Therapiae Experimentalis 42(1): 11-12
Guttmann, R.D. 1994: Clinical immunosuppression, lymphocyte subsets, and host defense mechanisms Transplantation Proceedings 26(4): 1847
Agarwal, D.; Chakravarty, J.; Sundar, S.; Gupta, V.; Bhatia, B.D. 2008: Correlation between clinical features and degree of immunosuppression in HIV infected children Indian Pediatrics 45(2): 140-143
Dewilde, A. 2002: Virus and immunosuppression. 3d Seminar on Clinical Virology, Nancy, October 11 and 12, 2001 Annales de Biologie Clinique 60(4): 485-498
Rao, K.V.; Andersen, R.C. 1989: The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation Transplantation Proceedings 21(1 Part 2): 1652
Monaco, A.P.; Wood, M.L.; Maki, T.; Gozzo, J.J. 1989: Future strategies in immunosuppression: problems and potential for the induction of specific unresponsiveness to organ allografts in clinical transplantation Transplantation Proceedings 21(6): 3939-3942
Garin, A.M.; Gorbunova, V.A.; Bychkov, M.B.; Mindra, N.V.; Stenina, M.B.; Topchieva, S.V.; Treshchalina, E.M.; Chitiia, L.V.; Sdvizhkov, A.M.; Borisov, V.I.; Gurov, S.N.; Gershanovich, M.L.; Makhnova, E.V.; Nebol'sin, V.E. 2004: Results of a multicenter, phase-Ii clinical trial of Dicarbamin used to shield leukopoiesis in cancer patients with immunosuppression due to chemotherapy Voprosy Onkologii 50(2): 184-188
Knight, R.J.; Kurrle, R.; McClain, J.; Racenberg, J.; Baghdahsarian, V.; Kerman, R.; Lewis, R.; van Buren, C.T.; Kahan, B.D. 1994: Clinical evaluation of induction immunosuppression with a murine IgG2b monoclonal antibody (BMA 031) directed toward the human alpha/beta-T cell receptor Transplantation 57(11): 1581-1588
Shapira, Y.; Shohami, E. 1993: Experimental studies on brain oedema after blunt head injury: experimental approaches from animal experimentation to actual or possible clinical application European Journal of Anaesthesiology 10(3): 155-173
Schück, O. 2002: History of the Institute for Clinical and Experimental Medicine (IKEM), a research institute for experimental therapy Casopis Lekaru Ceskych 141(7): 226-227
Miyazaki, M.; Nioka, S.; Fujita, T. 1975: Use of various beta-adrenergic blockers in clinical anesthesia. (5) Clinical and experimental use of practolol (Eraldin) Masui. Japanese Journal of Anesthesiology 24(1): 56-63
Melichar, M. 1986: Experimental clinical evaluation of therapeutic preparations as an example of pharmaceutico-clinical cooperation Ceskoslovenska Farmacie 35(4): 189-192
Laiblin, C.; Bayşu, N.; Müller, M. 1978: Clinical study on experimental Theileria annulata infections of cattle. 1. Clinical-chemical studies Berliner und Munchener Tierarztliche Wochenschrift 91(2): 25-27
Nagot, N.; Ouedraogo, A.; Konate, I.; Weiss, H.A.; Foulongne, V.; Defer, M.C.; Sanon, A.; Becquart, P.; Segondy, M.; Sawadogo, A.; Van de Perre, P.; Mayaud, P.; Bahembera, E.; Berthe, A.; Coulibaly, M.; Defer, M.-C.; Diallo, R.; Djagbare, D.; Konate, I.; Ky-Dama, F.; M'Boutiki, G.T.; Meda, N.; Millogo, I.; Ouedraogo, A.; Ouedraogo, D.; Rouet, F.ço.; Sanon, A.; Sawadogo, H.; Vallo, R.; Andonaba, J.-B.; Sawadogo, A.; Mayaud, P.; Weiss, H.A.; Nagot, N.; Becquart, P.; Foulongne, V.; Segondy, M.; Van de Perre, P. 2008: Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels Journal of Infectious Diseases 198(2): 241-249
Kobayashi, N.; Tanimura, H.; Inamoto, T.; Sato, T.; Hikasa, Y.; Setoyama, M.; Mukaihara, S.; Mine, Y. 1984: Experimental and clinical evaluation of small peptides as a nitrogen source in enteral nutrition (II). Clinical application of T-330 and a comparative study with Elental Nihon Geka Hokan. Archiv für Japanische Chirurgie 53(1): 133-144
Ryss, E.S.; Riabov, S.I.; Lutoshkin, M.B. 1996: A comparative evaluation of the efficacy of the clinical use of SKN-4M-, SKT-6A- and polifepan-type sorbents in treating patients with chronic kidney failure (clinical and experimental studies) Terapevticheskii Arkhiv 68(8): 39-43